Skip to content
KO EN
AI 기술 Upcoming

UiPath Rebound Erases OpenAI Presence Selloff, but ARR Math Sets Next Test

UiPath (NYSE: PATH) shares have rallied for four consecutive sessions, fully recovering the losses triggered by OpenAI 's launch of 'Presence' on July 22.

UiPath (NYSE: PATH) shares have rallied for four consecutive sessions, fully recovering the losses triggered by OpenAI‘s launch of ‘Presence’ on July 22. The stock closed at $12.19 on Tuesday, up 4.9%, surpassing its July 21 close. While the rebound appears encouraging, a closer look reveals several reasons for caution. The real test lies ahead: whether the company’s annual recurring revenue (ARR) hits its guided range when fiscal second-quarter results are reported.

OpenAI’s Presence Shakes the Market

On July 22, OpenAI introduced ‘Presence,’ an enterprise product for voice and chat agents that connects with company systems, policies, and human escalation. This directly competes with parts of UiPath‘s robotic process automation (RPA) market. The news sent UiPath shares plunging 11.1% on the day and another 4.7% the following day, reflecting strong market concern over a formidable new competitor.

Rebound Driver: Fundamentals or Short Covering?

Notably, the rebound occurred without any fresh company filings or earnings updates—the latest SEC filing remains a July 15 ownership report. Tuesday’s volume was 46.8 million shares, about 16% below the 65-day average, indicating limited participation relative to the price move. Meanwhile, short interest stood at 112.93 million shares as of July 15, representing 28.9% of the public float, down 18.7% from the prior period. This suggests that a significant portion of the rebound may be driven by short covering rather than fundamental improvement. Heavily shorted stocks can rally sharply on positioning shifts, but such moves are often temporary.

The Real Test: Slowing ARR Growth

The more fundamental challenge is ARR growth. Based on the midpoint of UiPath‘s guidance for the fiscal second quarter ending July 31, implied net-new ARR is approximately $30.5 million—about 38% below the first quarter. Revenue guidance also points to a roughly 5% sequential decline. This signals a slowdown in UiPath‘s core growth metric, which may be a more structural issue than the OpenAI threat. CEO Daniel Dines stated that agentic products are ‘moving from pilot to production,’ but concrete revenue contributions remain unclear.

Our Analysis: Competitive Landscape and Scenarios

XPLAIN AI interprets this situation as a critical test of UiPath‘s differentiation in the AI agent market. ServiceNow (NYSE: NOW) provided a positive peer signal last week, raising its annual subscription forecast after AI offerings surpassed $1 billion in annual contract value. This shows AI demand is boosting workflow automation, but it also highlights the competitive pressure on UiPath to prove its orchestration layer remains distinct from both OpenAI and ServiceNow.

Two scenarios emerge:

  • Favorable for UiPath: OpenAI’s entry could expand the overall agent automation market, driving demand for UiPath‘s governance and orchestration tools as enterprises seek to manage multiple AI agents. This could lead to a revaluation of UiPath‘s stock.
  • Unfavorable for UiPath: Presence may cause contract delays or weaken pricing power. If UiPath misses its ARR guidance range of $1.929 billion to $1.934 billion, short sellers could regain momentum, pushing the stock lower.

What to Watch Next

The true test will come with UiPath‘s fiscal second-quarter results, expected around September 3. Key metrics include whether ARR reaches the guided range and whether AI agent products are translating into tangible revenue. Until then, the recent rebound appears more positioning-led than growth-led, and investors should remain cautious.

#UiPath #OpenAI #AIagents #RPA #ARR #shortcovering #ServiceNow #automation

Sources

Written by: XPLAIN AI Editorial Team · Reviewed by: XPLAIN AI Editorial Desk
This content was drafted with AI assistance based on publicly available sources and reviewed under XPLAIN AI's editorial standards.

Found an error? Request a correction →